XBIO

Xenetic Biosciences, Inc.

4.21 USD
+0.04 (+0.96%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Xenetic Biosciences, Inc. stock is up 9.92% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.64% of the previous 12 July’s closed higher than June.

About Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc. focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology. The company has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC.